What triggered Injective's latest price pullback

Traders Union
All News
Crypto News
Injective slides 10.85% today to $4.90

Highlights

Injective faces continued selling pressure with no reported regulatory or ecosystem events affecting the recent price action.
Analysts point to persistent weakness in the broader crypto market as a backdrop for recent Injective moves.
Technical indicators signal bullish momentum but warn of short-term overbought conditions; expect consolidation between $4.28 and $5.83, with downside risk if support at $4.75 breaks.

Selling pressure lingers as analysts track lack of fresh catalysts

Cryptocurrency price evaluation for Injective featured in recent coverage, with attention on ongoing updates and historical analysis within the broader crypto market. Analysts have tracked trends over recent periods for Injective. No regulatory actions, ecosystem changes, or other factual corporate events have been reported in recent news, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, points to clear short-term weakness in Injective despite a bullish longer-term setup. He sees the 10.85% daily drop combined with high intraday volatility as a warning for bulls. Kharitonov highlights that mixed momentum signals and an overbought CCI flag potential exhaustion. The lack of fresh ecosystem news leaves sentiment exposed to further downside if $4.75 fails. "Short-term risks remain elevated — if the price slips below $4.75, deeper correction toward $4.28 becomes likely."

Viktoras Karapetjanc, expert at Traders Union, maintains a constructive stance on Injective. He notes the bullish structure is undisturbed, with prices above key moving averages and strong momentum on higher timeframes. Karapetjanc believes recent selling is a healthy pause in a larger uptrend. He sees a resilient outlook, citing no negative news or fundamental disruptions. "Further growth is expected — a push above $5.37 could quickly bring $5.83 into reach as market confidence returns."

Mixed intraday momentum as bullish technicals meet overbought signs

INJ/USD is currently trading above its 20-day ($4.55), 50-day ($3.76), and 200-day ($4.30) moving averages, confirming a bullish structure across short, medium, and longer-term horizons. The nearest dynamic support is around the Ichimoku Kijun at $4.75, with resistance likely near the 50-day moving average and the $5.00 round level. Momentum signals are mixed on the daily timeframe: the MACD and Average Directional Index (ADX) indicate continued bullish momentum, while the Relative Strength Index (RSI) remains in buy territory at 67.64 but is approaching overbought. The Stochastic RSI sits neutral, and the Commodity Channel Index (CCI) is flashing overbought at 104.46. Bull/Bear Power (BBP) reveals buyers still dominate intraday action, though the overbought reading suggests some exhaustion. Awesome Oscillator also supports the broad bullish tone. INJ/USD dropped sharply today, falling 10.85% to $4.90 with a clear downside gap of around $0.34; the price now sits in the lower part of the daily range with intraday volatility at 13.05%. Intraday tone signals pressure after the open, as daily weakness diverges from stronger daily momentum indicators.

Earlier, analysts noted that Injective was displaying sustained bullish momentum while signaling emerging downside risk due to heightened volatility. The latest market behavior reinforces this caution, with traders now advised to monitor the $4.75 support closely amid increasing volatility and a prevailing risk of further decline.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.